Oncolytic adenovirus-mediated expression of CCL5 and IL12 facilitates CA9-targeting CAR-T therapy against renal cell carcinoma
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncolytic adenovirus-mediated expression of CCL5 and IL12 facilitates CA9-targeting CAR-T therapy against renal cell carcinoma
Authors
Keywords
-
Journal
PHARMACOLOGICAL RESEARCH
Volume 189, Issue -, Pages 106701
Publisher
Elsevier BV
Online
2023-02-15
DOI
10.1016/j.phrs.2023.106701
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overview of the pre-clinical and clinical studies about the use of CAR-T cell therapy of cancer combined with oncolytic viruses
- (2022) Ali Zarezadeh Mehrabadi et al. World Journal of Surgical Oncology
- Strategies for Improving the Efficacy of CAR T Cells in Solid Cancers
- (2022) Jon Amund Kyte Cancers
- Cancer Immunotherapy and Delivery System: An Update
- (2022) Ming Yang et al. Pharmaceutics
- Anti‐tumor efficacy of human anti‐c‐met CAR‐T cells against papillary renal cell carcinoma in an orthotopic model
- (2021) Jun‐ich Mori et al. CANCER SCIENCE
- Renal cell carcinoma pathology in 2021: ‘new need for renal cancer immune profiling’
- (2021) Bettina Sobottka et al. CURRENT OPINION IN UROLOGY
- Oncolytic adenovirus-mediated expression of decorin facilitates CAIX-targeting CAR-T therapy against renal cell carcinoma
- (2021) Chen Zhang et al. Molecular Therapy-Oncolytics
- Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers
- (2020) Ha Thi Thu Do et al. Cancers
- Strategies for enhancing intratumoral spread of oncolytic adenoviruses
- (2020) Nasser Hashemi Goradel et al. PHARMACOLOGY & THERAPEUTICS
- Oncolytic virotherapy: Challenges and solutions
- (2020) Nasser Hashemi Goradel et al. CURRENT PROBLEMS IN CANCER
- Cancer stem cell-targeted chimeric antigen receptor (CAR)-T cell therapy: Challenges and prospects
- (2020) Javad Masoumi et al. Acta Pharmaceutica Sinica B
- Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer Treatment
- (2020) Norihiro Watanabe et al. MOLECULAR THERAPY
- An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer
- (2019) Steven Feins et al. AMERICAN JOURNAL OF HEMATOLOGY
- Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors
- (2019) Denarda Dangaj et al. CANCER CELL
- Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies
- (2019) Xiao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Combination of CTLA-4 and PD-1 blockers for treatment of cancer
- (2019) Anand Rotte JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The role of allogeneic HSCT after CAR T cells for acute lymphoblastic leukemia
- (2019) Elad Jacoby BONE MARROW TRANSPLANTATION
- Clinical lessons learned from the first leg of the CAR T cell journey
- (2019) Robbie G. Majzner et al. NATURE MEDICINE
- Current challenges and emerging opportunities of CAR-T cell therapies
- (2019) Teresa R. Abreu et al. JOURNAL OF CONTROLLED RELEASE
- Engineering strategies to overcome the current roadblocks in CAR T cell therapy
- (2019) Sarwish Rafiq et al. Nature Reviews Clinical Oncology
- Renal cell carcinoma in one year: Going inside the news of 2017 – A report of the main advances in RCC cancer research
- (2018) Claudia Mosillo et al. CANCER TREATMENT REVIEWS
- Emerging IL-12 family cytokines in the fight against fungal infections
- (2018) Aiysha Thompson et al. CYTOKINE
- Chimeric Antigen Receptor Therapy
- (2018) Carl H. June et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions
- (2018) Aly-Khan A. Lalani et al. EUROPEAN UROLOGY
- CAR-T Cells and Oncolytic Viruses: Joining Forces to Overcome the Solid Tumor Challenge
- (2018) Sonia Guedan et al. Frontiers in Immunology
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor-Transduced Human T cells in Solid Tumors
- (2014) E. K. Moon et al. CLINICAL CANCER RESEARCH
- Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity
- (2013) Cor HJ Lamers et al. MOLECULAR THERAPY
- Penton-Dodecahedral Particles Trigger Opening of Intercellular Junctions and Facilitate Viral Spread during Adenovirus Serotype 3 Infection of Epithelial Cells
- (2013) Zhuo-Zhuang Lu et al. PLoS Pathogens
- The three main stumbling blocks for anticancer T cells
- (2012) Lukas Baitsch et al. TRENDS IN IMMUNOLOGY
- Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
- (2011) Antonio Di Stasi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Carbonic Anhydrase IX in Renal Cell Carcinoma: Implications for Prognosis, Diagnosis, and Therapy
- (2010) Alexander B. Stillebroer et al. EUROPEAN UROLOGY
- Jekyll and Hyde: the role of the microenvironment on the progression of cancer
- (2010) Michael Allen et al. JOURNAL OF PATHOLOGY
- Hyaluronidase Expression by an Oncolytic Adenovirus Enhances Its Intratumoral Spread and Suppresses Tumor Growth
- (2010) Sonia Guedan et al. MOLECULAR THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now